Gabrielle Gershon

Gabrielle Gershon

Auto-generated profile, based on publicly available information

Gabrielle Gershon

Department of Radiology and Imaging Sciences, Emory University, 101 Woodruff Cir, Ste 308A, Atlanta, GA 30322

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2026 in European Heart Journal
Verified
Journal Article
Open access
TDTheodorus Dapamede
Theodorus Dapamede
AUAisha Urooj
Aisha Urooj
VJVedant Joshi
Vedant Joshi
GGGabrielle Gershon
Gabrielle Gershon
FLFrank Li
Frank Li
HTHari Trivedi
Hari Trivedi
Background and Aims: Women are underdiagnosed and undertreated for cardiovascular disease (CVD). Automatic quantification of breast arterial calcification (BAC) on screening mammography can identify women at risk for CVD. This study aimed to determine whether artificial intelligence–based automatic quantification of BAC from screening mammograms predicts CVD and mortality beyond PREVENT scores in a large, racially diverse, multi-institutional population. Methods: This retrospective cohort study included 123 762 women from two healthcare systems who had screening mammograms. Breast arterial calcification was quantified using a transformer-based neural network for segmentation. Breast arterial calcification severity was categorized as zero (0 mm2), mild (>0–10 mm2), moderate (>10–25 mm2), and severe (>25 mm2). Kaplan–Meier analysis, Cox proportional hazards, and Fine–Gray competing event models were used to examine the association between BAC and major adverse cardiovascular events (MACE). Results: Breast arterial calcification was detected in 16.1% (internal cohort) and 20.6% (external cohort) of women and provided significant prognostic value incremental to the PREVENT score. In PREVENT adjusted models, a clear dose–response was observed. Compared with zero BAC, mild [internal: hazard ratio (HR) 1.32, 95% confidence interval (CI) 1.10–1.59; external: HR 1.28, 95% CI 1.17–1.39], moderate (internal: HR 1.75, 95% CI 1.23–2.50; external: HR 1.79, 95% CI 1.55–2.06), and severe BAC (internal: HR 3.29, 95% CI 2.15–5.05; external: HR 2.80, 95% CI 2.36–3.32) were all prognostic for any MACE. Each 1 mm2 increase in BAC conferred an additional 2%–3% risk for MACE (P < .001). Conclusions: Automatically quantified BAC is an independent predictor of MACE and mortality, adding prognostic value to the PREVENT score. This approach may provide an opportunistic cardiovascular risk assessment during routine mammography screening without additional radiation exposure to guide earlier and more effective preventive care for women.

2 January 2026 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
GGGabrielle Gershon
Gabrielle Gershon
KZKari Zhou
Kari Zhou
YYYan Yang
Yan Yang
XYXinyue Yan
Xinyue Yan
JBJaret Barr
Jaret Barr
MAMarly van Assen
Marly van Assen

1 August 2026 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
EMEshan Momin
Eshan Momin
JBJaret Barr
Jaret Barr
GGGabrielle Gershon
Gabrielle Gershon
BZBrian Yieng Zhou
Brian Yieng Zhou
SRSaikiran Rapaka
Saikiran Rapaka
MAMarly van Assen
Marly van Assen
Coronary artery calcium (CAC) CT–derived cardiac chamber volumes improved heart failure risk predictions over the PREVENT-HF clinical risk and CAC scores, enabling reliable chamber dilatation assessment in asymptomatic individuals.